HAUSMAN DIANA
SEC CIK 1563992 · EDGAR
BoughtSold
Most active insiders at IMRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Feinberg Peter | Dir | $225.7K | — |
| 2 | Schall Thomas J. | Dir | $101.1K | — |
| 3 | Hall Brett Matthew | CSO | $35.5K | — |
| 4 | Brakewood Harold Eugene | Chief Business Off | $25.0K | — |
| 5 | Neufeld Leah R | CHRO | $16.0K | — |
| 6 | Zeskind Benjamin J. | Pres AND CEO, Dir | $10.9K | — |
| 7 | Bookman Michael | CLO, Sec | $6,967 | — |
| 8 | Morales Mallory | CAO | $1,917 | — |
HAUSMAN DIANA made no open-market trades at IMRX in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-07 | 2025-07-02 | IMRX | Immuneering Corp | HAUSMAN DIANA | Dir | P - Purchase | $3.60 | +2,500 | 2,500 | New | +$9,000 | |
| I | 2025-07-07 | 2025-07-02 | IMRX | Immuneering Corp | HAUSMAN DIANA | Dir | P - Purchase | $3.62 | +3,000 | 3,000 | New | +$10.9K |
| 2024-05-09 | 2024-05-09 | ZNTL | Zentalis Pharmaceuticals, Inc. | HAUSMAN DIANA | Chief Medical Off | S - Sale | $12.62 | -3,356 | 373.9K | -0.9% | -$42.4K | |
| D | 2024-02-05 | 2024-02-01 | ZNTL | Zentalis Pharmaceuticals, Inc. | HAUSMAN DIANA | Chief Medical Off | A - Grant | $0.00 | +337.5K | 377.2K | +849% | $0 |
| 2023-05-10 | 2023-05-08 | ZNTL | Zentalis Pharmaceuticals, Inc. | HAUSMAN DIANA | Dir | A - Grant | $0.00 | +39.7K | 39.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations